We’re passionate about unlocking the science and realising the potential of plants.
And we’ve built our business around it. As leading experts in the research, regulation and manufacturing of naturally-derived extracts, we’re developing the ingredients for next-generation therapeutics that will positively impact quality of life around the globe. Redefining the potential of botanicals for human health.
Quality drives value – and value is the focus of everything we do.
With over 40 years of proven capability, we have cultivated loyalty amongst the industry’s leaders. As a consistent authoritative source of regulatory insight, quality product and scientific expertise.
We’re relentless in delivering what the customer needs. Everything they require and nothing they don’t. From research, to agriculture, to manufacturing, we confidently deliver on expectations.
Setting the standard for efficiency and excellence.
We don’t have clients. We have partners.
We grow. We flex. We adapt. Going above and beyond to deliver tailored solutions that work for you. From specific supplies to a range of phased processing, we complement your capabilities by refining our deliverables.
We see the value in every relationship; from farmer to customer, employee to investor. And all levels of government. Collaboration is core to our sustainable business. We support, empower and guide our partners.
We invest in the power of Tasmania’s natural resources to grow the best possible ingredients for human wellness.
Supporting local agriculture, we’ve rooted our operations in an environment where plants and our community continue to thrive.
We are the leading scientists and experts in unlocking the value of botanical ingredients. Optimising every part through breeding. We source the best raw materials, invest in sustainable farming and lead quality control from seed to product.
Extracting the potential of nature for human health.
We innovate commercially to our evolving industry. Mapping out potential pathways through genetics and regulation.
We create solutions that are at the leading edge of science and regulation so you can focus on what matters and what is necessary.
We are the most trusted advisors and manufacturers for controlled substance extracts. We don’t just follow standards, but proudly set the bar.
We challenge and create what’s next.
We are constantly redefining excellence. Creating value for our clients. And delivering relentless reliability. We cultivate an ambitious attitude towards improvement to safeguard our success.
We honour the customer and all else will follow. We are dedicated to building strong working relationships through collaboration, transparency and mutual respect. We foster a culture of empowerment, diversity and fun.
We’re brave in pursuit of innovation. We set our standards higher, constantly striving for better. Finding new ways to improve the wellbeing of our people, the environment, human health.
We support sustainable farming and the economic viability of family farms and communities. We believe the foundation of our business and community is in the land and its people.
Tasmanian Alkaloids was established in 1975 in a small rural town (Westbury) in Tasmania surrounded by world-renowned pristine natural beauty, rich soils and the ability to produce exceptional agricultural products.
Over the past 40 years we have grown to be a world leading fully integrated manufacturer and exporter of controlled substance extracts focused on positively impacting quality of life around the globe.
We are an established world leader in supply of medicinal opiates and a predominant player in the medicinal cannabis market but also further cement our standing as a global leader in the production of high-valued plant-derived products for the healthcare market.
Highlights of his career include CEO of Avecho Biotechnology (formally Phosphagenics) based in Australia, Senior Vice President at Shire Pharmaceuticals (one of the world’s leading Specialty Pharmaceutical companies), based in the USA and Switzerland, where he founded and grew both the Emerging Products Business and Haematology Business, and President and COO of Prana Biotechnology Limited based in Australia.
Dr Murdoch has a BSc degree with honours from Monash University, a PhD in Clinical Pharmacology from the University of Melbourne, and additional postgraduate training in Health Economics from Monash University Business School
From 2013 -2016 Mr Ralph as General Manager reported into Johnson & Johnson’s, Janssen Supply Chain Global Platform Leader (Small Molecules) and had responsibilities for all Tasmanian Alkaloids Supply Chain site activities.
Previous roles held at Tasmanian Alkaloids (now Extractas Bioscience) included Business Development Director, accountable for Third Party manufacturing agreements, organisation of Tasmanian Alkaloid resources and the sites major capital expansion projects. The role also partnered with Johnson & Johnson World Wide Narcotics Franchise (WWNF) functions to develop strategies for source of raw materials including alternate geographies.
In 2011 Mr Ralph was selected and participated in the J&J International Development Program, and completed a project based in Athens Georgia USA for the WWNF looking at the systems that governed the movement of finished goods into the US for non-US based customers and suppliers.
Mr Ralph held numerous positions prior to this at Tasmanian Alkaloids within Operations and the Quality Functions, has worked with APIs and NRMs, has fronted FDA, TGA regulatory audits across his tenure.
Outside of Extractas Bioscience, Mr Ralph has worked within the Australian Education system within their Science and Finance departments, as well as abroad in the UK, for Jacobs Engineering and Glaxo-Wellcome within their Quality Control Functional groups.
Ian was also part of the Johnson & Johnson Finance Director leadership team for Australia & New Zealand which represented the combined statutory entity.
Ian had finance stewardship of the business which extended to both the Worldwide Narcotics Franchise and the manufacturing platform which operated as Janssen Supply Chain.
Prior to Tasmanian Alkaloids Ian spent 28 years in the Packaging Industry working for Rheem, South Australia Brewing, and Southcorp Packaging which was acquired by Visy Industries in 2001.
He had finance responsibility for the Food Packaging Division which operated (6) manufacturing sites across Australia. He was also part of the Visy finance leadership group which incorporated the Board, Paper, Recycling, Beverage, and Food Divisions.
Ian is based in the Melbourne office.
Prior to joining Tasmanian Alkaloids, Sally-Ann had an extensive career with Federal Group, working in the Gaming and Hospitality Industry, commencing in operations, then moving into a management role before studying and transitioning into the field of HR. She held a variety of generalist and specialist roles with Federal Group, working with Corporate Services, Gaming & Entertainment and the Tourism Business Units. Highlights include completing the HR aspects for the acquisitions of Cradle Mountain Chateau, the Henry Jones Art Hotel and the development of the unique Saffire of Freycinet.
Sally-Ann has a passion for coaching and leadership development, a fascination with neuroscience and how this can be related to behaviours in the workplace. She sees strategic planning, change management, real time data and relationship management as the pillars to business success.
Peta began her career at Tasmanian Alkaloids (now Extractas Bioscience) in 1997 in Analytical Services and was the Analytical Services Manager before moving into Sales in 2012.
Peta holds a Bachelor of Applied Science, majoring in Applied Chemistry & Biology from the University of Tasmania. She holds a Green Belt in both DMAIIC and DeX. She has also completed Black Belt training in Lean.
